Global Information
회사소개 | 문의 | 위시리스트

세계의 이온 채널 모듈레이터 시장

Ion Channel Modulators

리서치사 Global Industry Analysts, Inc.
발행일 2019년 05월 상품 코드 269629
페이지 정보 영문 151 Pages
가격
US $ 5,600 ₩ 6,728,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,800 ₩ 20,185,000 PDF by E-mail (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 이온 채널 모듈레이터 시장 Ion Channel Modulators
발행일 : 2019년 05월 페이지 정보 : 영문 151 Pages

세계의 이온 채널 모듈레이터(Ion Channel Modulators) 시장에 대해 조사했으며, 시장 개요와 경쟁 동향, 제품 개요, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

제1장 서론, 조사 방법, 제품의 정의

제2장 개요

  • 전망
    • 이온 채널 모듈레이터 : 후퇴하는 시장
    • 현재 및 향후 분석
    • 고령화
    • 경쟁 시나리오
    • 특허 만료
  • 업계 개요
  • 제품 개요
    • 이온 채널 모듈레이터 : 서론
    • 이온 채널의 생물학적 중요성
    • 질환 치료 옵션으로서의 이온 채널 모듈레이터
    • 이온 채널의 종류 등
  • 최근 업계 활동
  • 주요 기업
    • Allergan plc
    • AstraZeneca
    • Bayer HealthCare Pharmaceuticals
    • Biogen, Inc.
    • GlaxoSmithKline Plc.
    • H. Lundbeck A/S
    • Johnson & Johnson
    • Novartis AG
    • Parion Sciences, Inc.
    • Pfizer, Inc.
    • Sanofi S.A.
  • 세계 시장 전망

제3장 시장

  • 미국
  • 캐나다
  • 일본
  • 유럽
  • 기타 국가
KSA 18.01.29

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 39 companies including many key and niche players such as -

Allergan plc
AstraZeneca
Bayer HealthCare Pharmaceuticals
Biogen, Inc.
GlaxoSmithKline Plc
H. Lundbeck A/S

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Ion Channel Modulators - A Receding Market
  • Current and Future Analysis
  • Aging Population: Creating Need for More Efficient and Safe Drugs
    • Table 1: Global Population Worldwide: Percentage Share Breakdown by Age Group for the year 2025 (includes corresponding Graph/Chart)
    • Table 2: Global Population of People Aged 65+ Years (In Million) for the Years 2012, 2020 & 2050 (includes corresponding Graph/Chart)
  • Competitive Scenario
    • Table 3: Leading Ion Channel Modulators Worldwide: 2016 (Percentage Breakdown of Revenues) (includes corresponding Graph/Chart)
  • Patent Expiries of Select Ion Channel Modulators

2. INDUSTRY OVERVIEW

  • Ion Channels - A Peek into Their Types, Functional Use and Diversity
  • Ion Channels - Difficult Drug Targets
  • Currently Available Ion Channel Modulating Drugs in the Market
  • Select Ion Channel Modulator Drugs by Mode of Action
  • Ion Channel Modulators by Therapeutic Indication
  • Cardiovascular Diseases/ Hypertension
    • Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
  • Arrhythmia Treatment
  • Convulsions
  • Pain Management
  • Oncology
  • Diabetes
  • Ion Channel Modulation of Antiemetics
  • Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
  • Other Therapeutic Areas
  • Ion Channel Screening Aided by APC
  • Growing Interest in Outsourcing of Ion Channel Services
  • Selectivity against Subtypes - Need of the Hour for Na Channel Blockers
  • Select First Gen Sodium Ion Channel Modulators and Indications
  • Sodium Channel Subtypes, Specific Tissues and Indications
  • Strong Potential Na Channel Blockers for Use in Neuropathic Pain
  • New Trial Questions Nifedipine's Use for Treating Chronic Chilblains

3. PRODUCT OVERVIEW

  • Ion Channel Modulators: An Introduction
  • Biological Significance of Ion Channels
  • Ion Channel Modulators as an Option for Treating Diseases
  • Types of Ion Channels
  • Voltage-Gated Ion Channels
  • Extracellular Ligand-gated Ion Channels
  • Intracellular Ligand-gated Ion Channels

4. RECENT INDUSTRY ACTIVITY

  • Xenon Pharmaceuticals Begins Phase I Trials on XEN1101 Potassium Channel Opener
  • AstraZeneca Inks Agreement with Aspen for Residual Rights to its Anesthetics Portfolio
  • Parion Grants Global Rights for P-321 to Shire
  • Xenon Adds XEN1101 Potassium Channel Modulator to Its Pipeline
  • Alvogen Recalls 24 Lots of Nifedipine
  • Parion Commences Phase II Clinical Trial of P-321
  • AstraZeneca Sells Rights of Anesthetics to Aspen
  • AstraZeneca Inks Licensing Deal with CMS
  • Evotec and Asahi Collaborate for Screening of Ion Channel Targets
  • Catalyst Merges with Targacept
  • XRpro Acquires Pfizer's Ion Channel Biology Platform
  • Vertex and Parion Team Up to Develop ENaC Inhibitors
  • Parion Initiates Enrollment for Phase II Clinical Trial for P-1037 in Cystic Fibrosis
  • Biogen Idec Changes Name to Biogen
  • Biogen Idec Acquires Convergence Pharmaceuticals
  • Pfizer Wins Court Ruling to Block Generic Versions of Lyrica Upto 2018
  • Forest Labs Discontinues Namenda 5/10 mg Tablets, Launches Namenda XR
  • Forest Files Lawsuit against Namenda Generic Manufacturers
  • Cytocentrics Bioscience Selects Drug Safety Testing Center as its Distributor in Japanese Market
  • Zalicus Licenses Its Entire Sodium Channel Modulator Program to AnaBios Corporation
  • EPIRUS Merges with Zalicus

5. FOCUS ON SELECT GLOBAL PLAYERS

  • Allergan plc (Ireland)
  • AstraZeneca (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Biogen, Inc. (USA)
  • GlaxoSmithKline Plc. (UK)
  • H. Lundbeck A/S (Denmark)
  • Johnson & Johnson (USA)
  • Novartis AG (Switzerland)
  • Parion Sciences, Inc. (USA)
  • Pfizer, Inc. (USA)
  • Sanofi S.A. (France)

6. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 10: World 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: The US Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 12: Canadian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 13: Japanese Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • Market Analysis
    • Table 14: European Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: European 8-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Sanofi S.A. - A Key Player
  • B. Market Analytics
    • Table 16: French Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Bayer HealthCare Pharmaceuticals - A Key German Player in the Ion Channel Modulator Market
  • B. Market Analytics
    • Table 17: German Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 18: Italian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 19: The UK Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 20: Spanish Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 21: Russian Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 22: Rest of Europe Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 23: Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 24: Rest of World Recent Past, Current and Future Analysis for Ion Channel Modulators Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Back to Top
전화 문의
F A Q
 
BCC Research